Nifty 50 Shrugs Off Volatility to Close 0.81% Higher as Pharma and Banking Bulls Return

The Indian equity markets kicked off the final week of April on a resilient note, with the Nifty 50 climbing nearly 195 points to reclaim the 24,000 level. The index touched an intraday high of 24,130.70 and a low of 23,936.20 before closing at 24,092.70, up 0.81%. The BSE Sensex mirrored the move, rising 0.83% to close just above 78,500 as buying in pharma, financials, and oil & gas outweighed selling pressure in IT and auto stocks.

Why Sun Pharma, IndusInd Bank & Reliance Became Today’s Top Gainers

Pharma stocks stole the show on Monday. Sun Pharmaceutical Industries surged nearly 7% (up 111.60 points to ₹1,732.00) after reports suggested its US generic pipeline gained regulatory traction. The Nifty Pharma index rose over 3%, with peers like Dr. Reddy’s and Cipla also closing higher.

IndusInd Bank added 6.37% (₹54.00 to ₹901.95), continuing its recent outperformance on expectations of robust quarterly business updates. Jio Financial Services rose 3.61% to ₹254.60, while Reliance Industries gained over 3% on the BSE, supported by a recovery in refining margins and retail momentum.

Investors also rotated into defensive pockets. FMCG names like Nestlé India and Hindustan Unilever edged higher, though they were not among the top Nifty gainers.

Shriram Finance, Axis Bank & BEL Drag Nifty, What Went Wrong?

On the flip side, Shriram Finance was the worst performer on the Nifty, falling 3.69% to close at ₹974.00. Profit booking hit the stock after a sharp recent run-up, with no major negative company-specific news.

Axis Bank declined nearly 3% (down ₹40.50 to ₹1,325.40) as private banking names faced mild pressure amid rising bond yields. Bharat Electronics Ltd (BEL) slipped 1.90% to ₹436.00, tracking weakness in defense ancillary stocks.

The Nifty IT index was among the laggards, though the fall was modest compared to last week’s carnage. HCL Tech, Infosys, and TCS ended with small losses as investors remained cautious ahead of fresh quarterly commentary from tier‑1 IT firms.

Broader Market Outperforms: Nifty Smallcap Gains 1%, Midcap Flat

While frontline indices saw a mixed bag, the broader market showed clear resilience. The Nifty Smallcap index added over 1%, and the Nifty Midcap index closed flat with a positive bias. Market breadth was heavily in favour of advances, 1,958 stocks rose on the NSE versus 594 declines, and on the BSE, 2,876 advanced.

Sectoral performance saw clear divergence:

• Top Gainers: Pharma (+3.2%), Financial Services (+1.8%), Oil & Gas (+1.5%), FMCG (+0.9%)
• Top Losers: IT (-0.6%), Auto (-0.4%), Private Banks (-0.3%)

Oil Near $100, India VIX Cools But Rupee Weakens – What It Means for Nifty

Despite today’s market rally, global headwinds haven’t disappeared. Brent crude oil futures for July delivery rose another 2.29% to trade at $101.40 per barrel, firmly above the $100 mark. The surge follows stalled US‑Iran negotiations and continued concerns over Strait of Hormuz closures. For India, a net oil importer, every $10 rise in crude adds roughly 0.5% to wholesale inflation.

Encouragingly, the India VIX which is the market’s fear gauge, fell 6.85% to 18.36, suggesting near‑term anxiety has eased slightly. However, the rupee weakened further to 94.19 against the US dollar (down 0.05%), extending its recent slide. A weaker rupee makes imports costlier and could prompt the RBI to intervene.

Conclusion: Nifty Holds 24,000 but Upside Capped by Oil & Global Cues

Monday’s session offered a much‑needed breather after last week’s IT‑driven selloff. The Nifty’s ability to close above the 20‑day Bollinger Band middle (23,693.62) and approach the 24,400 resistance zone is technically positive. However, with crude oil stubbornly above $100 and the rupee hovering near record lows, the rally’s sustainability remains questionable.

Investors are likely to stay stock‑specific, favouring pharma, utilities, and select financials while avoiding expensive IT and auto names. The coming days will be driven by global oil developments and any fresh domestic earnings surprises.